List view / Grid view
Medical screening is a strategy used to identify the possible presence of an as-yet-undiagnosed disease in individuals without signs or symptoms.
21 March 2019 | By NanoTemper Technologies
Current technologies that measure molecular interactions for drug discovery slow down and complicate screening. Dianthus is the answer to the demands for fast, non-stop, highly sensitive hit identification, hit validation and lead optimisation.
14 March 2019 | By Drug Target Review
In this In-Depth Focus: the importance of characterising chemical starting points of drugs using appropriate in vitro ADME-toxicity assays, and why do we have no effective treatments for osteoarthritis?
14 March 2019 | By Drug Target Review
In this issue: AI-driven automated chemistry as a tool to accelerate drug discovery processes, the shifting landscape of immuno-oncology, and how lipid molecules provide an insight into biological research.
14 March 2019 | By Iqra Farooq (Drug Target Review)
A machine-learning model has been developed to analyse protein sequences, giving an insight to their structure, function and phylogeny...
7 March 2019 | By Iqra Farooq (Drug Target Review)
A small molecule inhibitor has been observed to activate a dramatic reduction in tumour growth in EBV-associated tumours...
7 March 2019 | By Sphere Fluidics Ltd.
Learn more about an emerging high-throughput method for identifying and isolating rare cells secreting antigen-specific antibodies.
1 March 2019 | By Iqra Farooq (Drug Target Review)
A meta-analyses of a number of studies has found that variants in numerous genes work together to contribute to Tourette's syndrome...
26 February 2019 | By Iqra Farooq (Drug Target Review)
A recently developed microfluidics device is able to detect and separate out cancer cells in blood, without the need for dilution...
22 February 2019 | By Drug Target Review
A method of imaging calcium activity that is based on magnetic resonance imaging (MRI) could help to image deep within the brain...
18 February 2019 | By Tecan and Ncardia
Ncardia, will discuss the application of human iPSC-derived cell-based assays and high throughput screening for drug discovery and development.
15 February 2019 | By Iqra Farooq (Drug Target Review)
A method has been developed to reprogram stem cells using the measles virus vector, cutting a four-step process to only one stage...
14 February 2019 | By Iqra Farooq (Drug Target Review)
A blood test to measure pain has been developed, and could potentially aid physicians with more accuracy in diagnosis and prescriptions...
12 February 2019 | By Iqra Farooq (Drug Target Review)
Researchers have developed a method using PET imaging along with 18F-fluorofuranylnorprogesterone to analyse the efficacy of breast cancer treatments...
12 February 2019 | By Drug Target Review
A biomarker that can differentiate between chronic cystitis (inflammation of the bladder) and a non-muscle invasive-type blood cancer could aid diagnosis...
7 February 2019 | By Anthony Pinkerton
Small molecule drug discovery has long been the domain of pharmaceutical companies, and that’s not likely to change anytime soon. But there’s a cadre of universities and nonprofit research institutes that have embraced drug development at its earliest stages, in some cases identifying and optimising compounds that target possible disease-driving…
Follow: